NeuralEdge AI Group

Dashboard

TTM through Mar 2026, QuickBooks Online, last sync 2h ago

TTM Revenue

$14.2M

+28.4% YoY

Adj. EBITDA

$3.11M

21.9% margin

Gross Margin

42.8%

-180 bps QoQ

Cash Runway

14.2 mo

$2.4M cash, burn $169K

Revenue, last 24 months

Monthly recurring

Top signals

View all 6

Customer concentration risk

high

Helix Bio's contribution increased from 12.

Unusual journal entry pattern

high

12 manual JEs posted on Dec 31, 2025 totaling $284K of revenue.

Gross margin compression

high

Gross margin compressed from 43.

Days sales outstanding trending up

med

DSO increased from 47 days (Q3 2025) to 61 days (Q1 2026).

Diligence progress

View checklist
Quality of Earnings14 / 18
Legal & Corporate9 / 22
Commercial diligence6 / 15
Tech & security2 / 12

Recent activity

QBO sync completed, 2h ago

Pulled 1,847 GL entries, 3 new customers

New signal: Customer concentration, 4h ago

Helix Bio crossed 18% threshold

Report generated: Q4 QoE Summary, yesterday

By Rocky Hill, 22 pages

Checklist item completed, 2d ago

"Verify revenue recognition policy"

NeuralEdge AI GroupNeuralEdge AI Group1 of 2

Quarterly Investor Briefing, Q1 2026

NeuralEdge AI Group

Vertical SaaS for AI-native life-sciences workflows.

TTM Rev

$14.2M

EBITDA

$3.1M

NRR

124%

1 / 2·